Drug & medication recalls Moderate risk

Endophth Kit recalled over sterility concerns

Recall date
October 2, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Pine Pharmaceuticals, LLC recalls Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Compounded by Pine Pharmaceuticals 355 River…
Recall number
D-0052-2024
FDA classification
Class II
Brand / firm
Pine Pharmaceuticals, LLC
Sold / distributed
Nationwide within the United States

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Get recall alerts

Free email alert whenever Pine Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Pine Pharmaceuticals, LLC